BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 24477458)

  • 21. Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1α.
    Diers AR; Vayalil PK; Oliva CR; Griguer CE; Darley-Usmar V; Hurst DR; Welch DR; Landar A
    PLoS One; 2013; 8(6):e68348. PubMed ID: 23840849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells.
    Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K
    Int J Oncol; 2014 Jun; 44(6):2077-84. PubMed ID: 24718784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
    Agnihotri N; Kumar S; Mehta K
    Breast Cancer Res; 2013 Feb; 15(1):202. PubMed ID: 23673317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REST mediates resolution of HIF-dependent gene expression in prolonged hypoxia.
    Cavadas MA; Mesnieres M; Crifo B; Manresa MC; Selfridge AC; Scholz CC; Cummins EP; Cheong A; Taylor CT
    Sci Rep; 2015 Dec; 5():17851. PubMed ID: 26647819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
    Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
    Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.
    Triantafyllou EA; Georgatsou E; Mylonis I; Simos G; Paraskeva E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1142-1152. PubMed ID: 29908837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coenzyme Q
    Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC
    Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer.
    Ma J; Mi C; Wang KS; Lee JJ; Jin X
    Oncotarget; 2016 Jun; 7(24):36551-36562. PubMed ID: 27144516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.
    Altuntas S; Rossin F; Marsella C; D'Eletto M; Diaz-Hidalgo L; Farrace MG; Campanella M; Antonioli M; Fimia GM; Piacentini M
    Oncotarget; 2015 Dec; 6(42):44941-54. PubMed ID: 26702927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
    Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
    Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
    Han AL; Kumar S; Fok JY; Tyagi AK; Mehta K
    Eur J Cancer; 2014 Jun; 50(9):1685-96. PubMed ID: 24656569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypoxia/reoxygenation and lipopolysaccharide induced nuclear factor-ΚB and hypoxia-inducible factor-1α signaling pathways in intestinal epithelial cell injury and the interventional effect of emodin].
    Qi L; Yuan B; Fu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):409-14. PubMed ID: 24912640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells.
    Oh K; Lee OY; Park Y; Seo MW; Lee DS
    BMC Cancer; 2016 Sep; 16(1):724. PubMed ID: 27609180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.
    Fisher ML; Adhikary G; Xu W; Kerr C; Keillor JW; Eckert RL
    Oncotarget; 2015 Aug; 6(24):20525-39. PubMed ID: 25971211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue transglutaminase-mediated chemoresistance in cancer cells.
    Verma A; Mehta K
    Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.